Backs FY25 adjusted EBITDA view $240M-$250M. The company said, “As a reminder, full-year 2025 results reflect a full year of legacy Acuren (TIC) operations and approximately five months of contribution from NV5 following the August 4, 2025 acquisition.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TIC: